What is the interaction between Metoprolol (beta blocker) and Metformin (biguanide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Metoprolol and metformin can generally be used together safely with appropriate monitoring, as there is no significant pharmacokinetic interaction between these medications that would require dose adjustments or contraindicate their combined use. However, patients should be aware that both medications can affect blood glucose levels in different ways. Metoprolol, a beta-blocker, may mask symptoms of hypoglycemia such as increased heart rate and tremors, making it harder for patients to recognize when their blood sugar is low, as noted in various studies 1, 2, 3, 4, 5. It can also potentially cause slight increases in blood glucose levels in some patients. Metformin works to lower blood glucose by decreasing hepatic glucose production and improving insulin sensitivity. When starting this combination, patients should monitor their blood glucose more frequently until they understand how the medications affect them individually.

Key Considerations

  • Healthcare providers should consider using cardioselective beta-blockers like metoprolol rather than non-selective ones in diabetic patients when possible, as they may have a more favorable effect on glucose metabolism.
  • Patients should report any unusual symptoms or significant changes in blood glucose control to their healthcare provider promptly.
  • The benefits of using metoprolol and metformin together typically outweigh the potential risks when properly monitored, especially considering the protective effects of metformin on kidney, heart, and liver functions, as highlighted in recent research 5.

Monitoring and Precautions

  • Patients with chronic kidney disease, congestive heart failure, or chronic liver disease should be closely monitored due to the potential risk of lactic acidosis associated with metformin use, although recent evidence suggests that the risk may be lower than previously thought 1, 5.
  • The incidence of lactic acidosis is low and not necessarily determined by the administration of metformin, but it is crucial to be aware of the signs and symptoms to ensure prompt treatment if necessary.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.